As a proof-of-concept, we report in this study that combining an anti-worm drug, an antibiotic that inhibits HSP90, and a histone deacetylase inhibitor can synergistically inhibit the proliferation of sixteen out of seventeen TNBC and IBC cell lines (Figure 1B). The gene discussed is HSP90AB1; the disease is inflammatory breast carcinoma.